Emmetrope Ophthalmics LLC is categorized under Commercial Biotechnical Research in Key Biscayne, FL and active since 2011.
Emmetrope Ophthalmics LLC was established in 2011, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.
If you are seeking more information, feel free to contact Jeffrey Goldberg at the company’s single location by writing to 104 Crandon Boulevard # 419, Key Biscayne, Florida FL 33149 or by phoning (786) 355-8233. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Emmetrope Ophthalmics LLC |
| Contact Person: | Jeffrey Goldberg |
| Address: | 104 Crandon Boulevard # 419, Key Biscayne, Florida 33149 |
| Phone Number: | (786) 355-8233 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Biotechnical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541711 |
| Share This Business: |
Emmetrope Ophthalmics LLC was started in 2011 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Jeffrey Goldberg for inquiries that concern Emmetrope Ophthalmics LLC by calling the company number (786) 355-8233, as your correspondence is most welcome. Additionally, the physical location of the single location of Emmetrope Ophthalmics LLC can be found at the coordinates 25.698726,-80.162714 as well as the street address 104 Crandon Boulevard # 419 in Key Biscayne, Florida 33149.
For its online presence, you may visit Emmetrope Ophthalmics LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.